The following discussion summarizes the significant factors affecting the
operating results, financial condition, liquidity and capital resources of
OVERVIEW We are a blank check company incorporated inDelaware onJanuary 27, 2021 for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar partnering transaction with one or more businesses that we have not yet identified (a "Partnering Transaction"). OnMay 28, 2021 , we consummated the initial public offering of 30,000,000 units (the "Units"). Each Unit consists of one share of Series A common stock,$0.0001 par value per share (the "Series A common stock" and such shares, the "Public Shares") and one-third of one redeemable warrant (the "Public Warrants"). Each whole Public Warrant will entitle the holder to purchase one share of Series A common stock at an exercise price of$11.50 per share, subject to adjustment. The Units were sold at an offering price of$10.00 per Unit, generating total gross proceeds of$300,000,000 . OnJune 3, 2021 , we issued an additional 4,500,000 Units (the "Over-Allotment Units") pursuant to the underwriters' exercise in full of their over-allotment option in connection with the initial public offering. The Over-Allotment Units were priced at$10.00 per Over-Allotment Unit, generating total gross proceeds of$45,000,000 . The term "IPO" as used herein generally refers to the consummation of the initial public offering onMay 28, 2021 and the underwriters' exercise in full of their over-allotment option onJune 3, 2021 . We incurred offering costs in connection with the IPO of$17,887,856 , of which$10,675,000 was for deferred underwriting commissions. OnMay 28, 2021 , in conjunction with the closing of the initial public offering, we consummated the private sale of 1,000,000 units (the "Private Placement Units") at a purchase price of$10.00 per Private Placement Unit to our sponsor,PHPC Sponsor, LLC (the "Sponsor"), generating total gross proceeds of$10,000,000 . Concurrently with the sale of the Over-Allotment Units, the Sponsor purchased an additional 90,000 Private Placement Units for total gross proceeds of$900,000 . Each Private Placement Unit consists of one share of Series A common stock ("the "Private Placement Shares") and one-third of one warrant, each whole warrant entitling the Sponsor to purchase one share of Series A common stock at an exercise price of$11.50 per share (the "Private Placement Warrants"). The term "Private Placement" as used herein generally refers to the consummation of the private sale of Private Placement Units onMay 28, 2021 and the private sale of Private Placement Units in conjunction with the sale of the Over-Allotment Units onJune 3, 2021 . Of the gross proceeds received from the IPO and Private Placement,$345,000,000 (or$10.00 per Unit sold in the IPO) was deposited in a trust account (the "Trust Account") located inthe United States (the "U.S.") withContinental Stock Transfer & Trust Company acting as trustee. Our Sponsor, executive officers and directors (the "initial stockholders") agreed not to propose an amendment to our amended and restated certificate of incorporation that would modify the substance or timing of our obligation to provide holders of our Public Shares the right to have their shares redeemed in connection with a Partnering Transaction or to redeem 100% of our Public Shares if we do not complete a Partnering Transaction within 24 months from the closing of our IPO, orMay 28, 2023 , or 27 months, orAugust 28, 2023 , following an agreement in principle event, which means we have executed a letter of intent, agreement in principle or definitive agreement for a Partnering Transaction within 24 months from the closing of the IPO but have not completed the Partnering Transaction within such 24-month period (such 24-month or 27-month period, the "Combination Period") or with respect to any other provision relating to the rights of holders of Public Shares (the "Public Stockholders"), unless we provide the Public Stockholders with the opportunity to redeem their shares of Series A common stock in conjunction with any such amendment. We expect to continue to incur significant costs in the pursuit of a Partnering Transaction. We cannot assure you that our plans to complete a Partnering Transaction will be successful. 18
--------------------------------------------------------------------------------
Table of Contents
RESULTS OF OPERATIONS
As of
LIQUIDITY AND CAPITAL RESOURCES
As of
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The preparation of our financial statements and related disclosures in
conformity with accounting principles generally accepted in
19
--------------------------------------------------------------------------------
Table of Contents
at each reporting period. The Public Warrants were initially measured at fair value using a Monte Carlo simulation at their original issuance and subsequently measured using their quoted market price once they became actively traded on theNew York Stock Exchange during the third quarter of fiscal 2021. The fair value of the Private Placement Warrants was determined using a Black-Scholes Pricing Model using observable market data as the significant inputs (volatility, risk free rate and dividend yield). Series A Common Stock Subject to Possible Redemption We account for our Series A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480, "Distinguishing Liabilities from Equity" ("ASC 480"). Series A common stock subject to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable Series A common stock (including shares of Series A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, Series A common stock is classified as stockholders' equity. Our Series A common stock features certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, as ofSeptember 30, 2021 , 34,500,000 shares of Series A common stock subject to possible redemption were presented at redemption value as temporary equity, outside of stockholders' equity on our Condensed Balance Sheet. Net Earnings (Loss) per Share Basic and diluted earnings (loss) per share of Series A common stock subject to possible redemption (the "redeemable common stock") and the Series A common stock and Series F common stock not subject to possible redemption (collectively, the "non-redeemable common stock") is presented separately under the two-class method. Basic earnings (loss) per share is based on the average number of shares outstanding during the periods presented for the redeemable common stock and non-redeemable common stock. Net earnings is allocated between the redeemable common stock and non-redeemable common stock based on the weighted average shares outstanding during the periods presented. The redeemable common stock is measured at its redemption value each period. As allowed for within ASC 480, we have made an election to treat the portion of the remeasurement adjustment that exceeds fair value as an increase in income available to holders of shares of redeemable common stock and as a reduction of income available to holders of shares of non-redeemable common stock for basic and diluted earnings (loss) per share. Diluted earnings (loss) per share is based on the average number of shares of redeemable common stock and non-redeemable common stock used for the basic earnings per share calculation, adjusted for the dilutive effect of warrants, if any, using the "treasury stock" method. In addition, net earnings (loss) for diluted earnings per share is adjusted for the after-tax impact of changes to the fair value of derivative warrant liabilities, to the extent it is dilutive. We have not considered the effect of the warrants sold in the IPO and the Private Placement to purchase an aggregate 11,863,333 shares of Series A common stock in the calculation of diluted earnings (loss) per share, since the exercise of the warrants into shares of Series A common stock is contingent upon the occurrence of future events. See Note 6 within "Notes to Consolidated Financial Statements" for the calculation of basic and diluted earnings (loss) per share of redeemable common stock and non-redeemable common stock. RECENTLY ISSUED ACCOUNTING STANDARDS
See Note 4 within "Notes to Condensed Financial Statements" for a discussion regarding recently issued accounting standards.
CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS Forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, are made throughout this Quarterly Report on Form 10-Q (the "Quarterly Report"). These forward-looking statements are sometimes identified from the use of forward-looking words such as "believe," "should," "could," "potential," "continue," "expect," "project," "estimate," "predict," "anticipate," "aim," "intend," "plan," "forecast," "target," "is likely," "will," "can," "may" or "would" or the negative of these terms or similar expressions elsewhere in this Quarterly Report. Our financial condition, results of operations and cash flows may differ materially from those in the forward-looking statements. Such statements are based on management's current views and assumptions and involve risks and uncertainties that could affect expected results. Those risks and uncertainties include, but are not limited to, the following: •our being a newly incorporated company with no operating history and no revenues; •our ability to select an appropriate target business or businesses; •our ability to complete a Partnering Transaction; •our expectations around the performance of a prospective target business or businesses; 20
--------------------------------------------------------------------------------
Table of Contents
•our success in retaining or recruiting, or changes required in, our officers, key employees or directors following a Partnering Transaction; •our directors and officers allocating their time to other businesses and potentially having conflicts of interest with our business or in approving a Partnering Transaction; •actual and potential conflicts of interest relating to Post and its subsidiaries, the Sponsor and other entities in which members of our management team are involved; •our potential ability to obtain additional financing to complete a Partnering Transaction, including from the Sponsor, Post or other third parties; •our pool of prospective target businesses, including the location and industry of such target businesses; •our ability to consummate a Partnering Transaction due to the uncertainty resulting from the recent COVID-19 pandemic and other events (such as terrorist attacks, natural disasters or a significant outbreak of other infectious diseases); •the ability of our officers and directors to generate a number of potential Partnering Transaction opportunities; •the voting structure of our common stock, including any potential adverse effect on our ability to complete a Partnering Transaction timely or cost effectively, and, following a Partnering Transaction, our status as a controlled company and the ability of the Sponsor and Post to exercise control over our policies and operations, each as a result of the high vote feature of our Series B common stock; •our public securities' potential liquidity and trading; •the lack of a market for our securities; •the use of proceeds not held in the Trust Account or available to us from interest income on the Trust Account balance; •the Trust Account not being subject to claims of third parties; •the classification of our warrants as liabilities; •our financial performance; and •other risks and uncertainties included under "Risk Factors" within Item 1A of Part II of this Quarterly Report and in our prospectus for our IPO as filed with theU.S. Securities and Exchange Commission onMay 27, 2021 . You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. Moreover, we undertake no obligation to update publicly any forward-looking statements for any reason after the date of this Quarterly Report to conform these statements to actual results or to changes in our expectations.
© Edgar Online, source